• Leveraging Meta’s technologies, WhatsApp is transformed into a pivotal business tool that engages customers across their entire lifecycle, converting initial interest into qualified leads and direct purchases while maximising ROI. 
• Enabling seamless integration of third-party AI, Omnichat grants clients the ultimate flexibility to build a truly customised AI workforce on WhatsApp, establishing a complete social CRM and accelerating their digital transformation.
• Maxim’s Group deployed a seamless “conversation-to-commerce” journey on WhatsApp, directly driving significant business growth and enhancing customer experience by leveraging the platform’s convenience and cost-effective nature.
• MEDILASE bridged the online-to-offline (O2O) gap using a series of automated WhatsApp appointment booking flows, thereby increasing revenue and simultaneously driving new subscriber acquisition through interactive games.

HONG KONG, Jan. 20, 2026 /PRNewswire/ — Omnichat, a leading omnichannel AI customer experience platform offering conversational commerce solutions, recently hosted a highly scalable conference titled “Social CRM and AI”. Industry experts from the global social media giant Meta, well-known F&B group Maxim’s Hong Kong and the pioneering medical aesthetic provider MEDILASE, shared insights on the evolution of WhatsApp into a sophisticated platform for social CRM and conversational commerce, designed to deliver more personalised and connected customer experiences.

Omnichat, a Meta WhatsApp Business Solution Provider, announced the launch of its Omni AI Agent Studio at the event. This new studio builds upon Omnichat’s powerful native AI agents, including AI Customer Service Agent, AI Marketing Campaign Agent and AI Shopping Agent, which already provide extensive capabilities across the entire customer journey. The platform facilitates the seamless integration of these custom-built agents into any conversational workflow. Alan Chan, Founder and CEO of Omnichat, elaborated, “This launch signifies a pivotal moment in our commitment to democratising Agentic AI for businesses. When coupled with our advanced WhatsApp functionalities, including our Social Data Customer Platform and comprehensive WhatsApp loyalty program, our objective is to empower businesses to forge a powerful social CRM.” This enables businesses to consolidate customer profiles, conduct omnichannel customer analysis with conversational data across CRM and all social channels, and ultimately deliver highly engaging experiences precisely aligned with customer behaviour throughout the complete customer lifecycle.

The role of social messaging in the customer journey has fundamentally evolved, shifting from a simple support function to an integral part of the entire commerce experience. According to recent research by Kantar, 71% of Hong Kong consumers message a business via WhatsApp at least once a week. Silvie Lam, Business Director, Greater China at Meta, explained that consumer expectations have moved far beyond basic enquiries. “Customers no longer just expect WhatsApp to be a customer service channel,” Lam shared. “They now expect to be able to reach out to a brand via a messaging app immediately after discovering it through social ads.” Lam further elaborated on how Meta’s technologies are specifically designed to meet these new expectations, capture high-value sales moments and foster deeper, more profitable customer connections. Businesses can now manage and optimise the end-to-end customer journey by leveraging a powerful suite of tools within the WhatsApp ecosystem, such as Ads that Click to WhatsApp, Website-to-WhatsApp ads, WhatsApp Catalog, and WhatsApp Flows, eventually achieving omnichannel success.

Maxim’s Group has successfully engineered WhatsApp into a high-performing e-commerce channel to complement and expand the reach of its popular Eatizen membership app. By implementing Omnichat’s solutions, enhanced by Omni AI, Maxim’s leverages WhatsApp to engage both existing Eatizen members and new customers. The platform streamlines daily operations with intelligent chatbots while strategically driving sales through targeted, AI-segmented broadcast promotions.  Eileen Tang, Head of Digital Business of Maxim’s Caterers Limited, highlighted a landmark transactional success from their recent Mid-Autumn Festival seasonal sales. “We established a comprehensive, end-to-end WhatsApp buying journey,” Tang stated. “The results were immediate and profound, achieving a 2-3x higher Average Transaction Value compared to our traditional online marketplace channels.” Tang attributed this significant financial uplift to two core advantages. First, it offered a truly frictionless customer experience which allowed them to capture sales from a wider audience by empowering customers to order and pay directly within WhatsApp. Second, the approach was remarkably cost-effective, enabling Maxim’s Group to avoid the high costs associated with building complex new features within their existing app ecosystem. Maxim’s Group is now actively scaling its WhatsApp commerce strategy, positioning the channel as a key pillar for future business growth and deeper customer engagement in the digital-first era.

MEDILASE, an aesthetic beauty brand, has integrated online and offline experiences by utilising Omnichat’s WhatsApp API solutions. The company has automated critical touchpoints, including initial customer inquiries and key booking flows, such as treatment reminders and appointment confirmations, all delivered directly within WhatsApp. Omnichat’s centralised management platform has unified the workflows of our marketing, customer service, and sales teams, strengthening cross-departmental collaboration throughout the entire customer lifecycle. KC Ng, CEO of MEDILASE, explained the platform’s operational impact, “By leveraging the WhatsApp API solution, we’ve deployed 24/7 chatbots and achieved seamless cross-team collaboration, significantly elevating our service standards and operational transparency. Moreover, our chatbots systematically identify and anticipate customer needs, enabling staff to deliver higher-quality consultations that match each client with the right beauty treatment. This approach directly supports our core business goals, driving improvements in conversion and show-up rates.” He also specifically shared results from a recent campaign: “Approximately 40% of our customers participated in an interactive WhatsApp game, which successfully resulted in a 5% conversion rate.” MEDILASE aims to utilise Omnichat to enhance workforce efficiency, enabling our team to devote greater attention to specialised consultation and tailoring each beauty journey to the client’s unique needs.

The collaboration between Meta, Maxim’s Group, MEDILASE, and Omnichat at this event marks a pivotal moment for the future of customer engagement in Asia. The powerful case studies presented, powered by Omnichat’s solutions, combined with Meta’s strategic vision for WhatsApp to deliver a unified message: the integration of commerce and conversation is no longer a future concept but a present-day imperative for any brand seeking a definitive competitive edge. 

About Omnichat Limited

Founded in 2017 and headquartered in Hong Kong, Omnichat is a leading provider of AI-powered conversational commerce solutions for the Asia-Pacific region. Uniquely positioned as the sole Meta Business Partner and LINE Biz-Solutions Tech Partner in APAC with integrated WhatsApp, Facebook, Instagram, LINE, WeChat, and KakaoTalk capabilities, Omnichat empowers brands to centralise communications, deliver personalised experiences, and drive digital transformation across their operations. Over 5,000 brands, including international retailers and enterprises, leverage Omnichat to optimise their customer journeys.

Website: https://www.omnichat.ai/
WhatsApp: https://wa.me/85291925071/?text=EnquiryForWhatsApp
LinkedIn: https://hk.linkedin.com/company/omnichat-easychat
Facebook: https://www.facebook.com/OmnichatAI

For media enquiries, please contact:

Omnichat Limited

Lily Yeung
Regional Vice President of Communications
Tel: (852) 9803 5977
Email: lily.yeung@omnichat.ai 

Macy Chun
Communications Manager
Tel: (852) 6234 9555
Email: macy.chun@omnichat.ai

 

TAIPEI, Jan. 20, 2026 /PRNewswire/ — GEEKOM, long recognized as a pioneer and global leader in the mini PC industry, has built its reputation on delivering compact yet powerful computing solutions that combine innovation, reliability, and sleek design. The newly launched GEEKOM GeekBook X14 Pro is a laptop that offers premium specifications and a striking design, reflecting the brand’s commitment to performance and style, and it is now available for purchase.

The GeekBook X14 Pro is remarkably thin and lightweight, weighing just 2 pounds, with an aluminum chassis and soft-touch finish, and it opens and closes with one hand, making it among the most portable laptops in its class. Despite its slim profile, it rocks premium hardware designed to meet the needs of professionals, creators, and everyday users who demand both mobility and power.

At its core, the GeekBook X14 Pro is powered by the Intel Meteor Lake Ultra processor (up to the U9-185H). This cutting-edge chip integrates Intel Arc graphics, delivering powerful GPU performance for gaming, creative workloads, and smooth multimedia experiences.The processor is paired with 32GB of LPDDR5x RAM and a PCIe Gen4 SSD of up to 2TB, ensuring seamless multitasking, responsiveness, lightning-fast file transfers, and quick app launches.

The laptop’s display is another highlight. Featuring a 2.8K 120Hz OLED panel, the GeekBook X14 Pro offers vibrant colors, deep contrast, and fluid visuals – ideal for gaming, creative work, or immersive entertainment. Combined with its featherweight design, the device becomes a versatile companion for users on the go.

Security and privacy are front and center with the GeekBook X14 Pro. It features a fingerprint reader for secure logins and file encryption, along with a camera equipped with a physical privacy switch—giving users confidence in their digital safety. Complementing these protections is an impressive 16-hour battery life, ensuring peace of mind and productivity that lasts all day.

To enhance value, GEEKOM includes a versatile Type-C hub as a complimentary gift with every purchase. Beyond added functionality, buyers also benefit from a comprehensive 2-year warranty, ensuring reliable protection and long-term peace of mind.

Alongside the GeekBook X14 Pro, GEEKOM’s GeekBook X16 Pro is also now available. This larger sibling carries the same powerful specifications but steps up with a spacious 16-inch 2.5K IPS display. It also packs an even bigger battery, delivering up to 17 hours of endurance for extended productivity and entertainment.

Acquisition strengthens SAP, IT Infrastructure Services, and Cybersecurity capabilities, expands Kaizen’s presence in Japan, and adds a proven offshore delivery center in India.

ATLANTA and TOKYO and CHENNAI, India, Jan. 20, 2026 /PRNewswire/ — Kaizen Analytix, a global provider of AI, data analytics, and technology services, today announced the acquisition of Nihon Technology, an IT services company specializing in SAP implementation, Digital Transformation, and Cybersecurity.

The acquisition strengthens Kaizen’s ability to help enterprises modernize core systems while embedding analytics and AI into transformation programs from the outset.

Founded in 2007 and led by T. Muthuvelan, Nihon has built deep execution rigor and an operating model that aligns closely with Kaizen Analytix’ principles. Over the last 17 years, the company has delivered 300+ engagements for customers in the Manufacturing, Retail and Technology industries. Nihon’s leadership team will continue to run the business with operational autonomy following the acquisition.

“As Kaizen grows globally, we are being intentional about where we invest and how we build differentiated capability,” said Krishna Arangode, Founder & CEO of Kaizen Analytix. “Japan is a strategically important market that values trust, and long-term partnerships. Nihon brings deep SAP, Digital Transformation and Cybersecurity expertise, a proven Japan–India delivery model, and an execution mindset that aligns closely with Kaizen’s continuous improvement principles for people and process. Together, we are well positioned to support enterprises navigating increasingly complex transformation journeys.”

Connecting SAP Modernization with Data and AI
Nihon’s strengths in SAP implementations, MES, analytics, enterprise data integration, and cybersecurity complement Kaizen’s broader portfolio across data engineering, advanced analytics, AI/ML, and Enterprise AI. The combination creates a more integrated transformation platform—connecting core ERP systems with intelligence, automation, and AI-driven decision-making.

Together, the combined organization will help clients:

• Modernize ERP landscapes with analytics and AI embedded from day one
• Accelerate enterprise decision-making through trusted, data-driven insights
• Scale global delivery across regions with strong governance
• Reduce transformation risk through incremental, value-focused delivery

For Nihon’s clients, the acquisition expands access to Kaizen’s capabilities in AI-led transformation, advanced analytics, and large-scale data modernization.

“Joining Kaizen is a natural next chapter for Nihon,” said T. Muthuvelan, CEO of Nihon. “Our clients rely on us for execution excellence across enterprise solution implementations and cybersecurity. With Kaizen, we can bring additional capabilities in AI and analytics—without changing the delivery standards our clients’ trust.”

“What makes this combination powerful is the complementary nature of capabilities and operating models,” said Anand Srinivasan, Chief Operating Officer and Managing Partner at Kaizen Analytix. “Nihon brings deep Global delivery rigor with recognized quality certifications across enterprise modernization initiatives, which fits naturally with how Kaizen scales large, multi-year transformation programs. Together, we are now a unified, globally integrated team delivering measurable business outcomes – faster, smarter, and at scale!”

About Kaizen Analytix
Kaizen is a leading provider of AI, data analytics, and technology services and solutions. Kaizen combines strong business acumen, deep subject matter expertise, and technical know-how to rapidly uncover actionable insights and sustainable business benefits across the value chain. Recognized for speed and flexibility by Gartner, NPR, Forbes, Entrepreneur, and Inc. 5000 as one of America’s fastest-growing private companies, Kaizen is a certified minority-owned business headquartered in Atlanta with offices in 7 cities globally. Follow Kaizen on LinkedIn, Facebook, and Twitter @KaizenAnalytix.

About Nihon Technology
Nihon Technology is a trusted provider of ERP implementation, cybersecurity, and digital transformation services for enterprises operating in complex and regulated environments. With 17 years of operating history and 300+ successful enterprise engagements, Nihon supports 70+ enterprise clients through a delivery model built on quality, governance, and reliability. The company operates delivery teams across Japan and India and is recognized for consistent execution and long-term client partnerships.

Media Contact for Kaizen Analytix:

Paulette Brown
Carabiner Communications
pbrown@carabinercomms.com
770.577.3881

Photo – https://mma.prnewswire.com/media/2864476/Kaizen_Analytix__Strengthens_Japan_India_Delivery_Model_with_Nihon_Acquisition.jpg

SYDNEY, Jan. 20, 2026 /PRNewswire/ — Humanforce, a leading global provider of intelligent, AI-driven human capital management (HCM) solutions for frontline workforces, today announced the appointment of Cameron Partridge as Chief Growth Officer (CGO).

Cameron’s appointment is part of a drive to strengthen Humanforce’s senior leadership capability across Australia, the UK, and North America, following several high-level executive hires in recent months. In his role, he will lead the evolution of Humanforce’s global brand, mature its commercial operating model and accelerate expansion across key international markets.

Cameron is a globally recognised AI strategy and commercial leader with experience across private-equity-backed companies, high-growth scaleups and Fortune 50 organisations, including nearly a decade operating in the United States. Most recently, Cameron served as CMO of Invisible Technologies, one of North America’s fastest-growing AI companies, where he helped accelerate and scale commercial growth and operations, supporting enterprise customers such as DoorDash, Microsoft and AWS. He has previously held senior leadership roles at Macquarie Group, BBDO, and GE. 

Cameron said he was drawn to Humanforce by the strength of the executive team, the company’s leading position in the HR tech landscape and the strong scalability opportunity.

“Clayton and the senior leadership team are building Humanforce with an ambition and intensity that is rare in mid-market SaaS,” Cameron said. “The recent executive appointments signal a disciplined shift toward scale, accountability and global execution. It’s the kind of environment where meaningful, sustained growth can be created – not just talked about.”

Humanforce powers frontline workforces across healthcare, hospitality, childcare, retail, aged care, venues and major sporting organisations. Customers include Accor, Flight Centre, Hungry Jack’s, Vodafone, Fujitsu, Alfred Health, Hostplus — organisations operating in high-regulation, high-complexity environments where workforce management is mission-critical.

Humanforce has strengthened its leadership in frontline HCM by expanding its comprehensive, enterprise-ready platform across talent acquisition, engagement and financial wellbeing. This integrated model supports the full employee lifecycle within a single platform designed for scale, compliance and operational complexity.

“As AI reshapes knowledge and desk work, frontline labour is becoming more essential and more complex,” Cameron said. “For years, organisations had to choose between fragmented best-in-class tools or broad suites that underdelivered. Humanforce is the first platform to offer both – a full, integrated suite with genuinely best-in-class capability across compliance, scheduling, payroll and workforce intelligence. That’s a rare and strong place to be in today’s market.”

Humanforce CEO Clayton Pyne said Cameron’s appointment is a key step in strengthening the company’s position as the global leader in frontline HCM.

“Cameron has operated at the sharp edge of AI and modern commercial systems, bringing global experience and real scaling pedigree from high-growth companies,” said Clayton Pyne, Chief Executive Officer of Humanforce. “As we enter a new stage of global expansion and sharpen our focus on upmarket opportunities, his leadership will be central to how we shape our commercial engine, strengthen our market position and scale with discipline and speed.”

-ends-

About Humanforce

Humanforce provides the market leading, employee-centred, intelligent and compliant HCM suite for frontline and flexible workforces, offering highly configurable, all-in-one WFM, HR, Talent, Benefits and Payroll – without compromise. Our vision is to make work easier and life better by focusing on the employee experience (EX), and the efficiency and optimisation of businesses.

Founded in 2002, Humanforce has a 2300-strong customer base and is heading towards one million employees under management, across a wide range of industries including Aged Care, Childcare, Healthcare, Retail, Hospitality, Events & Stadia, Local Government and more. Today, we have offices across Australia, New Zealand, the United Kingdom, the Philippines, and the USA.

Customers include Accor, Flight Centre, Hungry Jack’s, Vodafone, Fujitsu, Alfred Health, Hostplus and more: https://humanforce.com

New lab advances webAI’s mission to build accessible, sovereign, and defensible intelligence for real-world deployment

AUSTIN, Texas, Jan. 20, 2026 /PRNewswire/ — webAI today announced the appointment of Dr. Paul J. Maykish as Chief Intelligence Officer and the launch of the webAI Intelligence Lab, a dedicated unit focused on building accessible, sovereign, and defensible intelligence across public sector and enterprise environments.

Dr. PJ Maykish joins webAI to lead the newly formed Intelligence Lab after serving as a Vice President for technology strategy at the Special Competitive Studies Project and Director for Technology Competition at the National Security Council. A 24-year veteran of military operations, Maykish previously directed classified research for the National Security Commission on Artificial Intelligence and commanded the U.S. Central Command’s Combined Air Operations Center, including commissioning AI programs in the ISIS war.

Under Dr. Maykish’s leadership, the Intelligence Lab will advance webAI’s long-term vision of Superintelligence built not as a single centralized model, but as a network of interoperable, domain-specific intelligence systems. These systems are designed to collaborate securely, operate locally, and compound in capability over time. All the while delivering practical, deployable improvements to webAI’s platform today.

“Our mission is simple, but non-negotiable: advance towards Artificial Superintelligence that is accessible, sovereign, and defensible,” said David Stout, founder and CEO of webAI. “We believe the future of intelligence is something you own, operate, and trust wherever it is needed. The Intelligence Lab exists to build that future.”

The webAI Intelligence Lab will focus on building systems designed for operational reliability, data sovereignty, and resilience in contested environments. Initial focus areas include:

• On-device and edge intelligence for local execution
• Architectures designed for security, integrity, and adversarial resistance
• Repeatable deployment patterns that scale across organizations and missions

“AI is rapidly becoming operational infrastructure, and the bar is rising,” said Dr. Maykish, Chief Intelligence Officer at webAI. “The Intelligence Lab will build systems that organizations can control end-to-end, from data to models to runtime, with performance and trust that hold up in the real world.”

The launch follows webAI’s recently announced funding and valuation milestone, which is accelerating hiring and investment across product, engineering, and deployment programs to meet growing demand for sovereign AI.

To learn more about webAI and the webAI Intelligence Lab, visit www.webai.com.

About webAI

webAI is the enterprise AI platform that brings AI to your data. Built for mission-critical environments, it enables organizations to build and operate private, custom models with complete data sovereignty, real-time performance, and predictable economics.

MELBOURNE, Australia and INDIANAPOLIS, Jan. 20, 2026 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces that the Chinese National Medical Products Administration (NMPA) Center for Drug Evaluation (CDE) has accepted the filing of a New Drug Application (NDA) for TLX591-Px (Illuccix®, Kit for the preparation of ⁶⁸Ga-PSMA-11), Telix’s lead prostate cancer imaging agent.

The NDA was submitted with Telix’s strategic partner for the Greater China region, Grand Pharmaceutical Group Limited (00512.HK, Grand Pharma). Seeking a broad label that reflects clinical utility at multiple stages of prostate cancer care, the submission includes data from the Illuccix China Pivotal Phase 3 Registration study^[1], which reported positive top-line results in December 2025^[2].

The Illuccix China study met its primary endpoint, with an overall patient-level positive predictive value (PPV) of 94.8% for the detection of tumors in patients with biochemical recurrence (BCR) of prostate cancer with TLX591-Px^[2],[3]. This confirmed that the clinical experience of TLX591-Px PSMA-PET^[4] imaging in Chinese patients is comparable to studies in non-Chinese patients. The high PPV was demonstrated even in patients with very low PSA^[5] values, and across differing metastatic locations. More than two-thirds (67.2%) of patients experienced a change in their treatment plan as a consequence of TLX591-Px PSMA-PET imaging compared with the initial plan at baseline^[3], demonstrating a major impact on clinical decision-making in Chinese patients.  

Kevin Richardson, Chief Executive Officer, Precision Medicine, Telix, commented, “Submitting this New Drug Application for TLX591-Px, the first for any of our products in China, is a major milestone for Telix and our partner Grand Pharma. Geographic expansion is core to the growth strategy for our precision medicine business, and China represents a strategically important market for Telix. We look forward to progressing regulatory approvals together with Grand Pharma and subject to NMPA approval, bringing our lead commercial imaging product to market in China to serve the needs of men living with prostate cancer.”

About Prostate Cancer in China

In China, more than 134,000 men were diagnosed with prostate cancer in 2022^[6], increasing by approximately 6% each year^[7]. In line with government policy supporting wider geographic access to nuclear medicine, the number of PET/CT cameras installed in China is expected to have surpassed 1,600 at the end of 2025^[8], compared with 133 in 2010^[9].

About Illuccix

Telix’s lead prostate imaging product, gallium-68 (⁶⁸Ga) gozetotide injection (also known as ⁶⁸Ga PSMA-11 and marketed under the brand name Illuccix®), has been approved by the U.S. Food and Drug Administration (FDA)^[10], by the Australian Therapeutic Goods Administration (TGA)^[11], by Health Canada^[12], by the Brazilian Health Regulatory Agency (ANVISA)^[13], by the United Kingdom (UK) Medicines and Healthcare Products Regulatory Agency (MHRA)^[14] and in 19 countries within the European Economic Area (EEA).

PSMA-PET imaging represents a significant advance in prostate cancer management, largely replacing conventional imaging methods such as bone scans and computed tomography (CT) scans as the standard of care after initial diagnosis and biochemical recurrence (BCR) in the United States. Global guidelines recognize its superior accuracy in staging primary disease and assessing BCR^[15].

About Telix Pharmaceuticals Limited

Telix is a biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. Telix is headquartered in Melbourne, Australia, with international operations in the United States, United Kingdom, Brazil, Canada, Europe (Belgium and Switzerland), and Japan. Telix is developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases. Telix is listed on the Australian Securities Exchange (ASX: TLX) and the Nasdaq Global Select Market (NASDAQ: TLX).

Illuccix® (kit for the preparation of gallium-68 (⁶⁸Ga) gozetotide injection), Telix’s first generation PSMA-PET imaging agent, has been approved in multiple markets globally.

Visit www.telixpharma.com for further information about Telix, including details of the latest share price, ASX and U.S. Securities and Exchange Commission (SEC) filings, investor and analyst presentations, news releases, event details and other publications that may be of interest. You can also follow Telix on LinkedIn, X and Facebook.

Telix Investor Relations (Global)

Ms. Kyahn Williamson
Telix Pharmaceuticals Limited
SVP Investor Relations and Corporate Communications
Email: kyahn.williamson@telixpharma.com

Telix Investor Relations (U.S.)  

Annie Kasparian 
Telix Pharmaceuticals Limited 
Director Investor Relations and Corporate Communications 
Email: annie.kasparian@telixpharma.com 

Media Contact

Eliza Schleifstein
917.763.8106 (Mobile)
Eliza@schleifsteinpr.com

This announcement has been authorized for release by the Telix Pharmaceuticals Limited Disclosure Committee on behalf of the Board.

Legal Notices

Cautionary Statement Regarding Forward-Looking Statements. 

You should read this announcement together with our risk factors, as disclosed in our most recently filed reports with the Australian Securities Exchange (ASX), U.S. Securities and Exchange Commission (SEC), including our Annual Report on Form 20-F filed with the SEC, or on our website.

The information contained in this announcement is not intended to be an offer for subscription, invitation or recommendation with respect to securities of Telix Pharmaceuticals Limited (Telix) in any jurisdiction, including the United States. The information and opinions contained in this announcement are subject to change without notification.  To the maximum extent permitted by law, Telix disclaims any obligation or undertaking to update or revise any information or opinions contained in this announcement, including any forward-looking statements (as referred to below), whether as a result of new information, future developments, a change in expectations or assumptions, or otherwise. No representation or warranty, express or implied, is made in relation to the accuracy or completeness of the information contained or opinions expressed in the course of this announcement.

This announcement may contain forward-looking statements, including within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, that relate to anticipated future events, financial performance, plans, strategies or business developments. Forward-looking statements can generally be identified by the use of words such as “may”, “expect”, “intend”, “plan”, “estimate”, “anticipate”, “believe”, “outlook”, “forecast” and “guidance”, or the negative of these words or other similar terms or expressions. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ materially from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Forward-looking statements are based on Telix’s good-faith assumptions as to the financial, market, regulatory and other risks and considerations that exist and affect Telix’s business and operations in the future and there can be no assurance that any of the assumptions will prove to be correct. In the context of Telix’s business, forward-looking statements may include, but are not limited to, statements about: the initiation, timing, progress, completion and results of Telix’s preclinical and clinical trials, and Telix’s research and development programs; Telix’s ability to advance product candidates into, enroll and successfully complete, clinical studies, including multi-national clinical trials; the timing or likelihood of regulatory filings and approvals for Telix’s product candidates, including the planned NDA resubmission for TLX101-Px and the planned BLA resubmission for TLX250-Px, manufacturing activities and product marketing activities; Telix’s sales, marketing and distribution and manufacturing capabilities and strategies; the commercialization of Telix’s product candidates, if or when they have been approved; Telix’s ability to obtain an adequate supply of raw materials at reasonable costs for its products and product candidates; estimates of Telix’s expenses, future revenues and capital requirements; Telix’s financial performance; developments relating to Telix’s competitors and industry; the anticipated impact of U.S. and foreign tariffs and other macroeconomic conditions on Telix’s business; and the pricing and reimbursement of Telix’s product candidates, if and after they have been approved. Telix’s actual results, performance or achievements may be materially different from those which may be expressed or implied by such statements, and the differences may be adverse. Accordingly, you should not place undue reliance on these forward-looking statements.

Trademarks and Trade Names. All trademarks and trade names referenced in this press release are the property of Telix Pharmaceuticals Limited (Telix) or, where applicable, the property of their respective owners. For convenience, trademarks and trade names may appear without the ® or ™ symbols. Such omissions are not intended to indicate any waiver of rights by Telix or the respective owners. Trademark registration status may vary from country to country. Telix does not intend the use or display of any third-party trademarks or trade names to imply any affiliation with, endorsement by, or sponsorship from those third parties.

©2026 Telix Pharmaceuticals Limited. All rights reserved.

[1] ClinicalTrials.gov ID: NCT05847348.
[2] Telix ASX disclosure 22 December 2025.
[3] Telix data on file. Illuccix China Clinical Study Report, December 2025.
[4] Imaging of prostate-specific membrane antigen with positron emission tomography.
[5] Prostate-specific antigen.
[6] Global Cancer Statistics 2022: GLOBOCAN survey. Published August 2024.
[7] Ye Dingwei et al. Lancet Oncology, 2022.
[8] Yang et al. J Nuc. Med. 2024.
[9] Goetz Partners research 2020.
[10] Telix ASX disclosure 20 December 2021.
[11] Telix ASX disclosure 2 November 2021.
[12] Telix ASX disclosure 14 October 2022.
[13] Telix ASX disclosure 18 March 2025.
[14] Telix ASX disclosure 13 February 2025.
[15] NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Prostate Cancer V.3.2026; EAU Guidelines. Edn. presented at the EAU Annual Congress Madrid 2025. ISBN 978-94-92671-29-5: https://uroweb.org/guidelines/prostate-cancer; Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. 2023: https://www.esmo.org/guidelines/guidelines-by-topic/esmo-clinical-practice-guidelines-genitourinary-cancers/clinical-practice-guidelines-prostate-cancer/eupdate-prostate-cancer-treatment-recommendations

LOS ANGELES, Jan. 20, 2026 /PRNewswire/ — GIGABYTE TECHNOLOGY Co. Ltd, a leading global manufacturer of motherboards, graphics cards, and hardware solutions, today unveiled the X870E AERO X3D WOOD at CES 2026. This new category of premium motherboards blends high-performance engineering with lifestyle-focused design.

As PCs increasingly move into open living and working spaces, X870E AERO X3D WOOD reimagines hardware as a design statement, bringing warmth and sophistication to high-end builds without compromising capability.

A New Aesthetic for a New Era of PC Design
Inspired by natural materials and modern interiors, the X870E AERO X3D WOOD reflects a shift toward design-driven hardware. The motherboard features wood-inspired accents and a premium leather pull tab, delivering a tactile and visual experience rarely seen in traditional PC components.

Designed for enthusiasts, creators, and gamers who value both form and function, X870E AERO X3D WOOD integrates naturally into lifestyle-focused PC setups, transforming hardware into a centerpiece rather than something to hide away. 

Flagship Performance Powered by AMD X3D
Beneath its refined exterior, X870E AERO X3D WOOD delivers uncompromising performance. Built on the AMD Socket AM5 platform, it supports the latest Ryzen™ 9000, 8000, and 7000 Series processors and enhances X3D performance through AI-assisted X3D Turbo Mode 2.0.

The motherboard supports DDR5 memory overclocking up to 9000MT/s and features a robust digital twin 16+2+2 phases VRM design for stable and efficient power delivery. Expansion capabilities include dual PCIe 5.0 slots for graphics cards and four M.2 slots supporting PCIe 5.0 / 4.0 x4 for ultra-fast storage.

Advanced Thermal Engineering with Elegant Integration
To maintain peak performance, X870E AERO X3D WOOD features a comprehensive thermal solution engineered for both efficiency and visual aesthetics.

Key thermal innovations include: 

• VRM Thermal Armor Advanced with high-efficiency heat pipes
• M.2 Thermal Guard L & M.2 Thermal Guard Ext.
• PCB Thermal Plate, improving thermal performance by 14% and adding structural stability. 

Next-Generation Connectivity and User-Friendly Features
Equipped with dual 5GbE LAN, Wi-Fi 7, and dual USB4 Type-C ports (DisplayPort Alt Mode/HDMI), the board includes GIGABYTE’s user-centric innovations: 

• DriverBIOS with pre-installed Wi-Fi drivers for instant network access
• M.2 EZ-Flex with a flexible patented baseplate for improved SSD cooling
• WIFI EZ-Plug for simplified antenna installation
• M.2 EZ-Latch Click & Plus for tool-free SSD installation 

For more information, please visit: 
Official Website: https://www.gigabyte.com/Motherboard/X870E-AERO-X3D-WOOD
Order Here: GIGABYTE X870E AERO X3D WOOD

AUCKLAND, New Zealand, Jan. 20, 2026 /PRNewswire/ — Jungheinrich, today, announced the Asia-Pacific launch of “AntOn by Jungheinrich“, a new value-focused material handling brand designed for businesses seeking reliable, straightforward, and cost-effective solutions for everyday operations.

AntOn by Jungheinrich delivers proven reliability, supported by German safety standards and testing expertise. Across the region, sustainability programmes and fleet modernisation initiatives are accelerating the shift toward electrified material handling equipment, reinforcing demand for lithium-ion solutions that balance performance, efficiency, and total cost of ownership.

The initial AntOn portfolio includes CBH 2.0, CBM 2.5, 3.0 and 3.5 tonne electric forklifts, delivering strong load capacities of 2,000 kg, 2,500 kg, 3,000 kg and 3,500 kg, travel speeds up to 17 km/h, and advanced lithium-ion batteries for rapid charging and extended operation, long service life, and minimal maintenance for reliable, efficient material handling in APAC markets. The portfolio is set to expand towards a full product range in the future.

The launch responds to strong growth in the Asia-Pacific’s material handling value segment, which is projected to expand at 8.1% by 2030.

In New Zealand, growth in logistics, warehousing, and infrastructure is driving demand for cost-effective, reliable material handling equipment. Rising operating costs and ESG expectations are accelerating the shift from internal combustion forklifts to electric solutions, with lithium-ion technology increasingly adopted for its lower total cost of ownership, zero maintenance, fast charging, and reliable multi-shift performance.

“The AntOn by Jungheinrich brand is a new product line combining ease of use, reliability and cost-effectiveness,” said Nadine Despineux, Member of the Board of Management, Sales at Jungheinrich. “We are specifically targeting companies that are looking for cost-effective and straightforward solutions for typical warehouse and transport requirements.”

Following a successful European debut with strong sales, AntOn by Jungheinrich is now available to customers in Asia-Pacific, supported through multi-channel sales, including e-commerce, direct sales, and selected partners and distributors.

“With more than 70 years of material handling expertise, Jungheinrich delivers end-to-end solutions supported by an established parts and service network across Asia-Pacific,” said Manojit Acharya, Vice President, Jungheinrich APAC.

For more information on the AntOn by Jungheinrich range, please visit: http://www.jungheinrich.co.nz. Interested in becoming an AntOn distributor? Please contact us directly at sales@jungheinrich.co.nz.

For media enquiries:

Jungheinrich
Daniel Lynch | daniel.lynch@jungheinrich.com.au | +61 423 922 202

Rothman & Roman (Appointed PR Agency)
Diana Estella | diana.estella@rothmanasia.com | +65 8498 9424